Kenneth J. Hillan

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index18.9kcitations72works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(16), Liver physiology and pathology(12), Cancer, Hypoxia, and Metabolism(9), Cancer Treatment and Pharmacology(9), Liver Disease Diagnosis and Treatment(6)

Publications72 total

Data from The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors
2023Open Access
Supplementary Data from Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
2023Open Access
Supplementary Table S1 from The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors
2023Open Access
Data from The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors
2023Open Access
Data from Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
2023Open Access
Supplementary Table S1 from The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors
2023Open Access
Data from Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
2023Open Access
Supplementary Data from Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
2023Open Access
Mucosal Addressin Cell Adhesion Molecule (MAdCAM-1) Expression Is Upregulated in the Cirrhotic Liver and Immunolocalises to the Peribiliary Plexus and Lymphoid Aggregates
Digestive Diseases and Sciences·2013· 23 cited
Distinct Chromosomal Alterations Segregate with SEPT6 Expression Levels in Leukaemia
Research Portal (Queen's University Belfast)·2012
Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
Clinical Cancer Research·2011· 99 citedOpen Access
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detection
Nature Methods·2007· 8 cited
Quantitative <I>In Situ</I> Hybridization of Tissue Microarrays
Humana Press eBooks·2006· 17 cited
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
Journal of Clinical Oncology·2005· 389 citedOpen Access
Altered patterns of transcription of the septin gene, <i>SEPT9</i>, in ovarian tumorigenesis
International Journal of Cancer·2005· 85 citedOpen Access
The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors
Clinical Cancer Research·2005· 106 citedOpen Access
The Septin-Binding Protein Anillin is Over-Expressed in Diverse Human Tumours
Research Portal (Queen's University Belfast)·2005
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
Journal of Clinical Oncology·2005· 1.5k citedOpen Access
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab
JNCI Journal of the National Cancer Institute·2005· 322 cited
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Biochemical and Biophysical Research Communications·2005· 964 cited
page 1 of 4Next →

Frequent Co-authors

Gretchen Frantz(13), Napoleone Ferrara(10), Franklin Peale(6), Audrey D. Goddard(5), Austin Gurney(5), Jennifer LeCouter(5), William Novotny(4), Linda Rangell(4), Zemin Zhang(4), Adrian M. Jubb(4), Hartmut Koeppen(4), Per Borgström(4), Peter A. Hall(4), Hans‐Peter Gerber(3), David A. Eberhard(3), Joe Kowalski(3), Gilbert-André Keller(3), David A. Lawrence(3), Patrick J. Dowd(3), Paul J. Godowski(3)